Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • masylichu
    Member
    • Oct 2010
    • 30

    #1

    cufflinks output against annotation file

    hello, everyone,

    i run the cufflinks to calculate the RPKM(or FPKM) for annotated genes for C.elegans.

    i type in the command.
    Code:
    cufflinks -p 8 -G WormBase190/ce6_sangerRNA.gtf N2.sort.bam
    the version of cufflinks is the latest, cufflinks-1.1.0.

    however, the output is like this.

    Code:
    chrI    Cufflinks   transcript  1738651 1738674 1   +   .   gene_id "Y71G12B.29"; transcript_id "Y71G12B.2
            9"; FPKM "0.0000000000"; frac "0.000000"; conf_lo "0.000000"; conf_hi "0.000000"; cov "0.000000";
    3>    2 chrI    Cufflinks   exon    1738651 1738674 1   +   .   gene_id "Y71G12B.29"; transcript_id "Y71G12B.29"; 
            exon_number "1"; FPKM "0.0000000000"; frac "0.000000"; conf_lo "0.000000"; conf_hi "0.000000"; cov "0.0000
            00";  
          3 chrI    Cufflinks   transcript  111292  111425  1   +   .   gene_id "F53G12.12"; transcript_id "F53G12.12"
            ; FPKM "0.0000000000"; frac "0.000000"; conf_lo "0.000000"; conf_hi "0.000000"; cov "0.000000";
    FPKM is 0.

    why ?
  • blanco
    Member
    • Apr 2012
    • 28

    #2
    It is not unusual (I think) that many transcripts have an FPKM of value 0 - just means that that transcript is not expressed.

    However if all transcripts have an FPKM value of 0 then something is wrong. My first guess would be that the chromosome names in the reference does not match the chromosome names in the annotation.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    22 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    27 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-13-2026, 09:56 AM
    0 responses
    22 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-09-2026, 11:14 AM
    0 responses
    28 views
    0 reactions
    Last Post SEQadmin2  
    Working...